Cite
Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis.
MLA
Köppen, Janett, et al. “Identification of Isoaspartate-Modified Transthyretin as Potential Target for Selective Immunotherapy of Transthyretin Amyloidosis.” Amyloid, May 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1080/13506129.2024.2358121.
APA
Köppen, J., Kleinschmidt, M., Morawski, M., Rahfeld, J.-U., Wermann, M., Cynis, H., Hegenbart, U., Daniel, C., Roßner, S., Schilling, S., & Schulze, A. (2024). Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis. Amyloid, 1–11. https://doi.org/10.1080/13506129.2024.2358121
Chicago
Köppen, Janett, Martin Kleinschmidt, Markus Morawski, Jens-Ulrich Rahfeld, Michael Wermann, Holger Cynis, Ute Hegenbart, et al. 2024. “Identification of Isoaspartate-Modified Transthyretin as Potential Target for Selective Immunotherapy of Transthyretin Amyloidosis.” Amyloid, May, 1–11. doi:10.1080/13506129.2024.2358121.